IMA logo

ImageneBio Inc

IMA
Healthcare|Biotechnology|US
$4.11
-0.06 (-1.44%)
DCF Value
$4.48
Tangible Book / Share
$8.79
Cash / Share
$8.42

Ownership Breakdown

63.9%
Float
11.4M
Shares Outstanding
7.3M
Float Shares

Major Holders (33)

Combined: 170.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
BVF Partners L P/IlIA, PN9.90%1,128,647Aug 14, 202613D/G
BVF Inc/IlCorporation9.90%1,128,647Aug 14, 202613D/G
Lampert Mark NIndividual9.90%1,128,647Aug 14, 202613D/G
Ortav YehudaiIndividual9.90%1,176,472Apr 21, 202613D/G
Trails Edge Biotechnology Master Fund, LPPartnership9.90%1,176,472Apr 21, 202613D/G
Trails Edge Capital Partners, LPIA, PN9.90%1,176,472Apr 21, 202613D/G
BVF GP Holdings LLCOther9.30%1,045,103Aug 14, 202613D/G
Blue Owl Capital Holdings LPPartnership8.51%959,337May 14, 202613D/G
Omega Fund VI, L.P.Partnership8.40%935,843Apr 21, 202613D/G
Omega Fund VI GP, L.P.Partnership8.40%935,843Apr 21, 202613D/G
Omega Fund VI GP Manager, Ltd.Other8.40%935,843Apr 21, 202613D/G
Claudio NessiIndividual8.40%935,843Apr 21, 202613D/G
Otello StampacchiaIndividual8.40%936,222Apr 21, 202613D/G
Ma-Weaver JacobIndividual5.80%643,933Jan 6, 202613D/G
Funicular Funds, LPPartnership5.80%643,933Jan 6, 202613D/G
Cable Car Capital, LPIA, PN5.80%643,933Jan 6, 202613D/G
Biotechnology Value Fund L PPartnership5.40%611,834Aug 14, 202613D/G
BVF I GP LLCOther5.40%611,834Aug 14, 202613D/G
Biotechnology Value Fund II LPPartnership3.80%433,269Aug 14, 202613D/G
BVF II GP LLCOther3.80%433,269Aug 14, 202613D/G
Atlas Venture Fund X, L.P.Partnership2.10%241,800Jul 29, 202513D/G
Atlas Venture Associates X, L.P.Partnership2.10%241,800Jul 29, 202513D/G
Atlas Venture Associates X, LLCOther2.10%241,800Jul 29, 202513D/G
BML Investment Partners, L.P.Partnership1.90%215,832Jul 28, 202513D/G
Leonard Braden MichaelIndividual1.90%220,832Jul 28, 202513D/G
Atlas Venture Fund XI, L.P.Partnership0.90%103,494Jul 29, 202513D/G
Atlas Venture Associates XI, L.P.Partnership0.90%103,494Jul 29, 202513D/G
Atlas Venture Associates XI, LLCOther0.90%103,494Jul 29, 202513D/G
Biotechnology Value Trading Fund OS LPPartnership0.60%66,808Aug 14, 202613D/G
BVF Partners OS Ltd.Corporation0.60%66,808Aug 14, 202613D/G
Atlas Venture Associates Opportunity I, LLCOther0.60%72,885Jul 29, 202513D/G
Atlas Venture Opportunity Fund I, L.P.Partnership0.60%72,885Jul 29, 202513D/G
Atlas Venture Associates Opportunity I, L.P.Partnership0.60%72,885Jul 29, 202513D/G

Insider Trades (100)

Last 4 quarters: 4,387,295 acquired · 436,869 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Yarema Kristindirector, officer: Chief Executive OfficerAug 14, 2026AWARD254,800——Form 4
Yarema Kristindirector, officer: Chief Executive OfficerAug 14, 2026AWARD250,000$5.84$1.5MForm 4
Yarema Kristindirector, officer: Chief Executive OfficerAug 14, 2026AWARD137,200$5.84$801.2KForm 4
Grant-Huerta YaninaChief Financial OfficerAug 14, 2026AWARD39,000——Form 4
Grant-Huerta YaninaChief Financial OfficerAug 14, 2026AWARD65,000——Form 4
Grant-Huerta YaninaChief Financial OfficerAug 14, 2026AWARD56,000$5.84$327.0KForm 4
Grant-Huerta YaninaJul 20, 2026OTHER0——Form 4
Yarema Kristindirector, officer: Chief Executive OfficerJul 25, 2026J115,129——Form 4
Yarema Kristindirector, officer: Chief Executive OfficerJul 25, 2026OPTION EX.38,376——Form 4
Yarema Kristindirector, officer: Chief Executive OfficerJul 25, 2026OPTION EX.38,376——Form 4
Yarema Kristindirector, officer: Chief Executive OfficerJul 25, 2026DISPOSED115,129——Form 4
Lally Robert BPrincipal Accounting OfficerJul 16, 2026SELL1,671$5.50$9.2KForm 4
Lally Robert BPrincipal Accounting OfficerJul 17, 2026SELL1,525$5.34$8.1KForm 4
Wang Jonathan JiandirectorJun 16, 2026AWARD15,600$5.45$85.0KForm 4
Stampacchia OtellodirectorJun 16, 2026AWARD15,600$5.45$85.0KForm 4
SLATTERY JOSEPH PdirectorJun 16, 2026AWARD15,600$5.45$85.0KForm 4
Bonita David PdirectorJun 16, 2026AWARD15,600$5.45$85.0KForm 4
Lally Robert BPrincipal Accounting OfficerMar 20, 2026OTHER0——Form 4
Lally Robert BPrincipal Accounting OfficerMar 20, 2026OTHER25,410$6.20$157.5KForm 4
Su Wei-guoApr 16, 2026OTHER0——Form 4
Bonita David PdirectorApr 14, 2026BUY384,689$0.00$384.69Form 4
Bonita David PdirectorApr 14, 2026BUY336,603$0.00$336.60Form 4
ORBIMED ADVISORS LLCdirectorApr 14, 2026BUY384,689$0.00$384.69Form 4
ORBIMED ADVISORS LLCdirectorApr 14, 2026BUY336,603$0.00$336.60Form 4
Yarema Kristindirector, officer: Chief Executive OfficerMar 16, 2026AWARD128,100$6.20$794.2KForm 4
Yarema Kristindirector, officer: Chief Executive OfficerMar 16, 2026AWARD85,400——Form 4
Porter-Brown BenjaminFeb 16, 2026OTHER0——Form 4
Butler ErinPrincipal Accounting OfficerDec 30, 2025AWARD22,500——Form 4
Butler ErinPrincipal Accounting OfficerDec 30, 2025AWARD22,500$7.11$160.0KForm 4
SLATTERY JOSEPH PdirectorDec 24, 2025BUY16,000$5.99$95.8KForm 4
Wang Jonathan JiandirectorDec 18, 2025AWARD31,200$6.19$193.1KForm 4
Wang Stephen HuidirectorDec 18, 2025AWARD31,200$6.19$193.1KForm 4
SLATTERY JOSEPH PdirectorDec 18, 2025AWARD31,200$6.19$193.1KForm 4
SLATTERY JOSEPH PNov 1, 2025OTHER0——Form 4
Wang Stephen HuidirectorJul 25, 2025AWARD188,042——Form 4
Wang Stephen HuidirectorJul 25, 2025AWARD50,144——Form 4
Wang Stephen HuidirectorJul 25, 2025AWARD12,535——Form 4
Wang Stephen HuiJul 25, 2025OTHER0——Form 4
Wang Jonathan JiandirectorJul 25, 2025AWARD971,173——Form 4
Wang Jonathan JiandirectorJul 25, 2025AWARD143,832——Form 4
Wang Jonathan JianJul 25, 2025OTHER0——Form 4
Lu YufangChief Medical OfficerJul 25, 2025AWARD38,137$28.72$1.1MForm 4
Lu YufangChief Medical OfficerJul 25, 2025AWARD27,459$4.59$126.0KForm 4
Lu YufangChief Medical OfficerJul 25, 2025AWARD6,102$4.59$28.0KForm 4
Lu YufangChief Medical OfficerJul 25, 2025AWARD4,591$4.59$21.1KForm 4
Lu YufangJul 25, 2025OTHER0——Form 4
Yarema Kristindirector, officer: Chief Executive OfficerJul 28, 2025AWARD460,515$16.37$7.5MForm 4
Yarema Kristindirector, officer: Chief Executive OfficerJul 28, 2025AWARD153,505——Form 4
ORBIMED ADVISORS LLCdirectorJul 25, 2025AWARD83,611$2.49$208.2KForm 4
Bonita David PdirectorJul 25, 2025BUY83,611$29.90$2.5MForm 4
Bonita David PdirectorJul 25, 2025OPTION EX.379——Form 4
Bonita David PdirectorJul 25, 2025OPTION EX.17,520$1.75$30.7KForm 4
Stampacchia OtellodirectorJul 25, 2025BUY267,556$29.90$8.0MForm 4
Stampacchia OtellodirectorJul 25, 2025OPTION EX.379——Form 4
Stampacchia OtellodirectorJul 25, 2025OPTION EX.17,520$1.75$30.7KForm 4
Marango JotinChief Financial OfficerJul 28, 2025AWARD15,776——Form 4
Marango JotinChief Financial OfficerJul 28, 2025TAX W/H4,630$17.16$79.5KForm 4
Marango JotinChief Financial OfficerJul 25, 2025DISPOSED397,199——Form 4
Butler ErinPrincipal Accounting OfficerJul 25, 2025AWARD3,813$4.59$17.5KForm 4
Butler ErinPrincipal Accounting OfficerJul 25, 2025AWARD3,051——Form 4
Butler ErinJul 25, 2025OTHER0——Form 4
Yarema KristinJul 25, 2025OTHER0——Form 4
FORMELA JEAN FRANCOISdirectorJun 7, 2024AWARD17,520$1.75$30.7KForm 4
Wooster RicharddirectorJun 7, 2024AWARD17,520$1.75$30.7KForm 4
Bonita David PdirectorJun 7, 2024AWARD17,520$1.75$30.7KForm 4
Dukes Iain D.directorJun 7, 2024AWARD17,520$1.75$30.7KForm 4
Hughes OwendirectorJun 7, 2024AWARD17,520$1.75$30.7KForm 4
Koehler MariadirectorJun 7, 2024AWARD17,520$1.75$30.7KForm 4
Stampacchia OtellodirectorJun 7, 2024AWARD17,520$1.75$30.7KForm 4
Germa CarolineChief Medical OfficerMar 1, 2024AWARD579,100$1.47$851.3KForm 4
Germa CarolineFeb 29, 2024OTHER0——Form 4
Ecsedy JeffreyChief Development OfficerFeb 1, 2024AWARD100,000$1.36$136.0KForm 4
Marango JotinCFO & Head of Corp. Dev.Feb 1, 2024AWARD181,000$1.36$246.2KForm 4
Manfredi Markdirector, officer: President & CEOFeb 1, 2024AWARD320,000$1.36$435.2KForm 4
Bonita David PdirectorAug 4, 2023AWARD153,121——Form 4
Bonita David PdirectorAug 4, 2023AWARD353,192——Form 4
ORBIMED ADVISORS LLCdirectorAug 4, 2023AWARD153,121——Form 4
ORBIMED ADVISORS LLCdirectorAug 4, 2023AWARD353,192——Form 4
Dukes Iain D.directorJun 9, 2023AWARD17,520$6.51$114.1KForm 4
Hughes OwendirectorJun 9, 2023AWARD17,520$6.51$114.1KForm 4
Stampacchia OtellodirectorJun 9, 2023AWARD17,520$6.51$114.1KForm 4
Koehler MariadirectorJun 9, 2023AWARD17,520$6.51$114.1KForm 4
Bonita David PdirectorJun 9, 2023AWARD17,520$6.51$114.1KForm 4
Wooster RicharddirectorJun 9, 2023AWARD17,520$6.51$114.1KForm 4
FORMELA JEAN FRANCOISdirectorJun 9, 2023AWARD17,520$6.51$114.1KForm 4
Santillana Sergio L.Chief Medical OfficerJan 3, 2023AWARD105,000——Form 4
Ecsedy JeffreyChief Development OfficerJan 3, 2023AWARD105,000——Form 4
Zhang Xiaoyan MichelleChief Scientific OfficerJan 3, 2023AWARD105,000——Form 4
Manfredi MarkPresident & CEOJan 3, 2023AWARD220,000——Form 4
Marango JotinCFO & Head of Corp. Dev.Jan 3, 2023AWARD105,000——Form 4
Hughes OwendirectorDec 15, 2022AWARD35,040——Form 4
Hughes OwenDec 14, 2022OTHER———Form 4
ORBIMED ADVISORS LLCdirectorJun 24, 2022BUY96,035$5.37$515.7KForm 4
ORBIMED ADVISORS LLCdirectorJun 24, 2022BUY65,965$4.37$288.3KForm 4
ORBIMED ADVISORS LLCdirectorJun 23, 2022BUY23,419$3.71$86.9KForm 4
OrbiMed Genesis GP LLCdirector: Jun 22, 2022BUY66,806$3.55$237.2KForm 4
ORBIMED ADVISORS LLCdirectorJun 22, 2022BUY66,806$3.55$237.2KForm 4
Bonita David PdirectorJun 24, 2022BUY96,035$5.37$515.7KForm 4
Bonita David PdirectorJun 24, 2022BUY65,965$4.37$288.3KForm 4
Bonita David Pdirector: Jun 22, 2022BUY23,419$3.71$86.9KForm 4